Inverted-Y ureteral duplications are an extremely rare variant of congenital ureteral malformation with few cases reported in the literature. We describe here a case of inverted-Y ureteral duplication with a blind-ending branch, which was managed by laparoscopic ureteroureterostomy with the intraoperative retrograde ureteroscopy-assisted technique. This is the first report that reveals that inverted-Y ureteral duplication was managed by ureteroureterostomy in a laparoscopic approach.

Keywords:
Ureteral duplication, Inverted-Y, Congenital, Laparoscopy
1.
Regan TC, Dejter SW Jr: Inverted Y duplication of the ureter with associated ureterocele and bladder outlet obstruction. J Urol 1996;155:642.
2.
Britt DB, Borden TA, Woodhead DM: Inverted Y ureteral duplication with a blind-ending branch. J Urol 1972;108:387-388.
3.
Mourad MS: Inverted Y ureteral duplication with a large ureterocele and draining a bifid renal pelvis in a man. J Urol 1997;157:1353.
4.
Suzuki S, Tsujimura S, Sugiura H: Inverted Y ureteral duplication with a ureteral stone in atretic segment. J Urol 1977;117:248-250.
5.
Upadhyay J, Zuckerman JM, Shekarriz B: Minimally invasive surgical approach to excision of symptomatic ectopic inverted-Y ureteral duplications. J Pediatr Urol 2013;9:e114-e116.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.